跳至主要内容
临床试验/KCT0008462
KCT0008462已完成Unknown

Survival benefit of living donor liver transplantation in patients with high model for end-stage liver disease (MELD) score

Yonsei University Health System, Severance Hospital0 个研究点目标入组 800 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
已完成
入组人数
800

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18(Year) 至 o Limit(—)
性别
All

入选标准

  • Between September 2005 and December 2021, patients with a MELD score >=30 who were on the waiting list for LT at Severance Hospital were retrospectively reviewed.

排除标准

  • hepatocellular carcinoma (HCC) with distant metastasis
  • any other malignancy diagnosed within 5 years
  • significant deterioration in health status within 2 days of placement on the waitlist

研究者

相似试验